Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Filip Jansåker, Jonas Bredtoft Boel, Sara Thønnings, Frederik Boëtius Hertz, Katrine Hartung Hansen, Niels Frimodt-Møller & Jenny Dahl Knudsen. (2019)
Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study. Infection and Drug Resistance 12, pages 1691-1702.
Read now
Read now
Articles from other publishers (34)
Paschalis Paranos, Sophia Vourli, Spyros Pournaras & Joseph Meletiadis. (2022) Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using In Silico Modelling. Pharmaceuticals 15:12, pages 1501.
Crossref
Crossref
Agne Giedraitiene, Laura Pereckaite, Evelina Bredelyte-Gruodiene, Marius Virgailis, Ieva Ciapiene & Vacis Tatarunas. (2022)
CTX-M-producing
Escherichia coli
strains: resistance to temocillin, fosfomycin, nitrofurantoin and biofilm formation
. Future Microbiology 17:10, pages 789-802.
Crossref
Crossref
Lars Plambeck, Frieder Fuchs, Janko Sattler & Axel Hamprecht. (2022)
In vitro
activity of mecillinam, temocillin and nitroxoline against MDR Enterobacterales
. JAC-Antimicrobial Resistance 4:3.
Crossref
Crossref
Hafiz Iftikhar Hussain, Zahid Iqbal, Mujahid Iqbal, Xiuhua Kuang, Yulian Wang, Lingquan Yang, Awais Ihsan, Amjad Islam Aqib, Qari Muhammad Kaleem, Yufeng Gu & Haihong Hao. (2022) Coexistence of virulence and β-lactamase genes in avian pathogenic Escherichia coli. Microbial Pathogenesis 163, pages 105389.
Crossref
Crossref
Adam G Stewart, Andrew Henderson, Michelle J Bauer, David L Paterson & Patrick N A Harris. (2022)
Activity of temocillin against third-generation cephalosporin-resistant
Escherichia coli
and
Klebsiella pneumoniae
bloodstream isolates from a clinical trial
. JAC-Antimicrobial Resistance 4:1.
Crossref
Crossref
Eva Raphael, M. Maria Glymour & Henry F. Chambers. (2021) Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system. Antimicrobial Resistance & Infection Control 10:1.
Crossref
Crossref
Pasqualina Laganà, Giuseppa Visalli, Alessio Facciolà, Marianna Pruiti Ciarello, Antonio Laganà, Daniela Iannazzo & Angela Di Pietro. (2021) Is the Antibacterial Activity of Multi-Walled Carbon Nanotubes (MWCNTs) Related to Antibiotic Resistance? An Assessment in Clinical Isolates. International Journal of Environmental Research and Public Health 18:17, pages 9310.
Crossref
Crossref
Hafiz Iftikhar Hussain, Amjad Islam Aqib, Mohamed N. Seleem, Muhammad Abubakar Shabbir, Haihong Hao, Zahid Iqbal, Muhammad Fakhar-e-Alam Kulyar, Tean Zaheer & Kun Li. (2021) Genetic basis of molecular mechanisms in β-lactam resistant gram-negative bacteria. Microbial Pathogenesis 158, pages 105040.
Crossref
Crossref
Eric Farfour, Anne-Gaëlle Si Larbi, Vincent Cattoir, Stéphane Corvec, Thomas Guillard, Antoine Grillon, Christophe Isnard, Audrey Mérens, Nicolas Degand, Typhaine Billard-Pomares, Damien Fournier, Emmanuelle Bille, Cécile Le Brun, Chloé Plouzeau, Emilie Flevin, Nicolas Yin, Paul-Louis Woerther, Julie Lourtet, Philippe Lesprit & Alban Le Monnier. (2021) Temocillin susceptibility among Enterobacterales strains recovered from blood culture in France. Diagnostic Microbiology and Infectious Disease 100:3, pages 115368.
Crossref
Crossref
Konstantinos Vazouras, Yingfen Hsia, Laura Folgori, Julia Bielicki, Elise Aguadisch, Alasdair Bamford, Ana Brett, Marion Caseris, Rimante Cerkauskiene, Maia De Luca, Elias Iosifidis, John Kopsidas, Ángela Manzanares, Tim Planche, Andrew Riordan, Tina Plankar Srovin, Ana Isabel Valdivielso Martínez, Eleni Vergadi, Mike Sharland & Romain Basmaci. (2020) Treatment and Outcomes of Children With Febrile Urinary Tract Infection Due to Extended Spectrum Beta-lactamase-producing Bacteria in Europe. Pediatric Infectious Disease Journal 39:12, pages 1081-1087.
Crossref
Crossref
Alicja Kuch, Bartłomiej Zieniuk, Dorota Żabicka, Sebastien Van de Velde, Elżbieta Literacka, Anna Skoczyńska & Waleria Hryniewicz. (2020) Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland. European Journal of Clinical Microbiology & Infectious Diseases 39:6, pages 1185-1191.
Crossref
Crossref
Rodrigo E. MendesPaul R. RhombergTroy ListerNicole CotroneoAileen RubioRobert K. Flamm. (2020) Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens. Microbial Drug Resistance 26:4, pages 319-328.
Crossref
Crossref
Heidi Syre, Marit Andrea Klokkhammer Hetland, Eva Bernhoff, Marianne Bollestad, Nils Grude, Gunnar Skov Simonsen & Iren Høyland Löhr. (2020)
Microbial risk factors for treatment failure of pivmecillinam in community‐acquired urinary tract infections caused by ESBL‐producing
Escherichia coli
. APMIS 128:3, pages 232-241.
Crossref
Crossref
Ilya Nikolaevich Zykov, Niels Frimodt-Møller, Lars Småbrekke, Arnfinn Sundsfjord & Ørjan Samuelsen. (2020) Efficacy of mecillinam against clinical multidrug-resistant Escherichia coli in a murine urinary tract infection model. International Journal of Antimicrobial Agents 55:2, pages 105851.
Crossref
Crossref
Fatih OCAK, Atilla ÇİFCİ, Salih CESUR & Sami KINIKLI. (2019) Genişlemiş spektrumlu beta-laktamaz üreten E. coli izolatlarının çeşitli antibiyotiklere duyarlılıklarının belirlenmesiDeterminating of susceptibilities to the various antibiotic of the extended-spectrum beta-lactamase producing E. coli isolates. Turkish Journal of Clinics and Laboratory 10:3, pages 384-387.
Crossref
Crossref
Nadeem S. Raja. (2019)
Emerging clinical role of pivmecillinam in the treatment of urinary tract infections caused by Extended Spectrum
βeta‐lactamase
(ESBL) producing
Enterobacteriaceae
. International Journal of Clinical Practice 73:9, pages 1-5.
Crossref
Crossref
A. Kara & M.K. Gurgoze. (2019) The use of nitrofurantoin for children with acute cystitis caused by extended-spectrum Β-lactamase–producing Escherichia coli. Journal of Pediatric Urology 15:4, pages 378.e1-378.e5.
Crossref
Crossref
Elise T. Zeiser, Scott A. Becka, Melissa D. Barnes, Magdalena A. Taracila, John J. LiPuma & Krisztina M. Papp-Wallace. (2019)
Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant
Burkholderia
Species Isolates from the United States
. Antimicrobial Agents and Chemotherapy 63:4.
Crossref
Crossref
C. Duployez, C. Loïez, C. Cattoen, F. Wallet & A. Vachée. (2019) In vitro activity of temocillin against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urinary tract infections in France. Médecine et Maladies Infectieuses 49:1, pages 47-53.
Crossref
Crossref
Marianne Bollestad, Nils Grude, Sigrid Solhaug, Niclas Raffelsberger, Nina Handal, Hans-Johnny Schjelderup Nilsen, Monica Regine Romstad, Andreas Emmert, Yngvar Tveten, Arne Søraas, Pål A Jenum, Synne Jenum, Janne Møller-Stray, Einar Tollaksen Weme, Morten Lindbaek & Gunnar Skov Simonsen. (2018) Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study. Journal of Antimicrobial Chemotherapy 73:9, pages 2503-2509.
Crossref
Crossref
K Alexandre, M Réveillon-Istin, R Fabre, V Delbos, M Etienne, M Pestel-Caron, S Dahyot & F Caron. (2018) Temocillin against Enterobacteriaceae isolates from community-acquired urinary tract infections: low rate of resistance and good accuracy of routine susceptibility testing methods. Journal of Antimicrobial Chemotherapy 73:7, pages 1848-1853.
Crossref
Crossref
Ilya Nikolaevich Zykov, Ørjan Samuelsen, Lotte Jakobsen, Lars Småbrekke, Dan I. Andersson, Arnfinn Sundsfjord & Niels Frimodt-Møller. (2018) Pharmacokinetics and Pharmacodynamics of Fosfomycin and Its Activity against Extended-Spectrum-β-Lactamase-, Plasmid-Mediated AmpC-, and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model. Antimicrobial Agents and Chemotherapy 62:6.
Crossref
Crossref
Aurore Bousquet, Sarah Bugier, Sébastien Larréché, Christine Bigaillon, Philippe Weber, Hervé Delacour, Eric Valade, Dominique De Briel & Audrey Mérens. (2018) Clinical isolates of Escherichia coli solely resistant to mecillinam: prevalence and epidemiology. International Journal of Antimicrobial Agents 51:3, pages 493-497.
Crossref
Crossref
Kevin Alexandre & Bruno Fantin. (2017) Pharmacokinetics and Pharmacodynamics of Temocillin. Clinical Pharmacokinetics 57:3, pages 287-296.
Crossref
Crossref
Benjamin Davido & Aurélien Dinh. (2018) Noncarbapenem ß-Lactams for the Treatment of Extended-Spectrum ß-Lactamase Infections: What Are the Remaining Drugs Outside the United States?. Clinical Infectious Diseases 66:2, pages 316-316.
Crossref
Crossref
Waleed M. Sweileh. (2017) Global research trends of World Health Organization’s top eight emerging pathogens. Globalization and Health 13:1.
Crossref
Crossref
Ma Su, Donglin Xia, Peng Teng, Alekhya Nimmagadda, Chao Zhang, Timothy Odom, Annie Cao, Yong Hu & Jianfeng Cai. (2017) Membrane-Active Hydantoin Derivatives as Antibiotic Agents. Journal of Medicinal Chemistry 60:20, pages 8456-8465.
Crossref
Crossref
M. Vallée, F. Bruyère, F. Roblot & L. Brureau. (2017) Place de la témocilline dans le traitement des infections urinaires. Progrès en Urologie 27:12, pages 609-617.
Crossref
Crossref
Gernot Zarfel, Michaela Lipp, Elena Gürtl, Bettina Folli, Rita Baumert & Clemens Kittinger. (2017) Troubled water under the bridge: Screening of River Mur water reveals dominance of CTX-M harboring Escherichia coli and for the first time an environmental VIM-1 producer in Austria. Science of The Total Environment 593-594, pages 399-405.
Crossref
Crossref
Takae Shimizu, Kazuki Harada, Yuzo Tsuyuki, Yui Kimura, Tadashi Miyamoto, Shingo Hatoya & Yoshiaki Hikasa. (2017) In vitro efficacy of 16 antimicrobial drugs against a large collection of β-lactamase-producing isolates of extraintestinal pathogenic Escherichia coli from dogs and cats. Journal of Medical Microbiology 66:8, pages 1085-1091.
Crossref
Crossref
Lisa Jacmel, Sandra Timsit, Agnès Ferroni, Clémentine Auregan, François Angoulvant & Gérard Chéron. (2017)
Extended-spectrum
β
-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre
. Acta Paediatrica 106:1, pages 142-147.
Crossref
Crossref
Karen Bush & Patricia A. Bradford. (2016) β-Lactams and β-Lactamase Inhibitors: An Overview. Cold Spring Harbor Perspectives in Medicine 6:8, pages a025247.
Crossref
Crossref
Jufeng Xia, Jianjun Gao & Wei Tang. (2016) Nosocomial infection and its molecular mechanisms of antibiotic resistance. BioScience Trends 10:1, pages 14-21.
Crossref
Crossref
Uwe Frank, Bidii Stephen Ngalah, Katharina Börner, Johanna Finkbeiner, Alexander Harter & Klaus Biehler. (2022) Combination of Isothiocyanates and Antibiotics Increases Susceptibility Against Acinetobacter Baumannii, Escherichia Coli, Klebsiella Pneumoniae, Proteus Mirabilis and Serratia Marcescens. SSRN Electronic Journal.
Crossref
Crossref